Category Archives: Biochemistry

Role Of Vitamin-D Supplementation In TB/HIV Co-Infected Patients | IDR – Dove Medical Press

Birhanu Ayelign, 1 Meseret Workneh, 1 Meseret Derbew Molla, 2 Gashaw Dessie 2

1Department of Immunology and Molecular Biology, School of Biomedical And Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; 2Department of Biochemistry, School of Medicine, College of Medicine And Health Sciences, University of Gondar, Gondar, Ethiopia

Correspondence: Birhanu Ayelign Email birhanuayelign42@gmail.com

Objective: This review aimed to assess the role of vitamin D supplementation on the decrement of mortality and morbidity rate among tuberculosis (TB)/human immune deficiency virus (HIV) co-infected clients.Method: Pub Med, google scholar and google search were accessed to find out all document to describe this review article.Results: Nowadays TB/HIV co-infection has become a major global concern, particularly in low and middle-income countries. Mycobacterium tuberculosis and HIV infections are co-endemic and more susceptible to the progression of TB. Immunosuppression associated with HIV is a strong risk factor for the reactivation of latent TB to the active form. Immune cells like macrophages recognized Mycobacterium tuberculosis through TLR2/1, and it increases the expression of the vitamin D receptor (VDR) and CYP27B1. The synthesis of 1,25-dihydroxy vitamin D promotes VDR-mediated transactivation of the antimicrobial peptide cathelicidin and the killing of intracellular Mycobacterium tuberculosis. Cathelicidins have a direct antimicrobial effect through membrane disruption. Besides, it has also antiviral effects via inhibition of retrovirus (HIV) replication. In fact, as some studies showed, there was a lower induction of cathelicidin in monocytes who have low vitamin D levels.Conclusion: Therefore, vitamin D supplementation can be directly involved in the reduction of TB/HIV co-infection and its progression.

Keywords: vitamin D, tuberculosis, HIV

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See the article here:
Role Of Vitamin-D Supplementation In TB/HIV Co-Infected Patients | IDR - Dove Medical Press

Mouse Lemurs Just Might Be the Next Big Thing in Genetics – Nature World News

Jan 08, 2020 11:04 AM EST

There are 500 animals studied so far in the mouse lemur project, a collaboration that aims to parse the genetics of this diminutive, prosimian primate. It is the brainchild of Stanford biochemist Mark Krasnow.

Because all 24 species of mouse lemurs look similar, the most reliable way for scientists to tell them apart is through genetic testing. (Scientists have recently identified three new species of mouse lemurs in Madagascar.)

They are quite possibly the answer to medical researchers' dreams.

This world's smallest primate may soon replace fruit flies, worms, and even mice as the primary lab animal for scientific research.

According to Stanford University School of Medicine researchers, they have the potential to serve as an ideal model for a wide range of primate biology, behavior, and medicine, including cardiovascular disease and Alzheimer's disease.

Mice, fruit flies, and worms as genetic models have routinely failed to mimic many aspects of primate biology, including many human diseases, said Mark Krasnow, MD, Ph.D., professor of biochemistry.

Krasnow and his colleagues turned to the mouse lemur and began conducting detailed physiologic and genetic studies on them.

It was reported that they already have identified more than 20 individual lemurs with unique genetic traits, including obesity, high cholesterol, high blood sugar, cardiac arrhythmias, progressive eye disease and motor and personality disorders.

The researchers hope it will soon become a genetic model organism that will help us better understand many aspects of primate biology, behavior, and health, including lemur and human diseases.

According to the June issue of GENETICS, Ezran et al.'s genetic research on these primates began as a project for three high school laboratory interns to find an appropriate model organism for primate genetics.

Mouse lemurs are more human than mice, as genetic research on mice has led to countless important discoveries, but their physiology and behavior differ in many ways from that of humans and other primates. They potentially rival the common laboratory mouse Mus musculus, at least for certain questions.

Mice, fruit flies, and worms were the prototypical lab specimen because they were inexpensive to maintain, easy to study, and reproduced quickly enough to offer researchers a constant stream of samples. According to Krasnow, MD, Ph.D., a professor of biochemistry at Stanford University, the genetic makeup of the 3 animals hasn't been a close enough match to humans to work well for the studies today's researchers need to conduct.

Krasnow's project is studying a large population of grey and brown mouse lemurs - Microcebus murinus and Microcebus rufus, respectively - in the wild to work out how their genes link to differences in biology, health, and behavior.

Other than being closely related to humans, they still have many of the advantages of mice in terms of small size, rapid reproduction, and relatively large litters.

These researchers hope that continued study of these abundant primates could lead to a better understanding, and possibly better treatments, of these and other conditions in lemurs and humans.

RELATED ARTICLE: DNA Analysis Helps Researchers Identify New Mouse Lemur Species

2018 NatureWorldNews.com All rights reserved. Do not reproduce without permission.

Read the original here:
Mouse Lemurs Just Might Be the Next Big Thing in Genetics - Nature World News

Ground Breaking CTE Research May Save the Future Game of Football – One Foot Down

Change is something we all experience in our lives. As we grow, our knowledge changes, our circle of influence changes, technology changes; pretty much everything changes. And as you look at the game of football, it too has changed a lot over the years. If you compare the college football of Rockne, to the college football of Parseghian, to the college football of Holtz, to the college football of Kelly; you are going to see many changes and advances within the sport. In my eyes, the biggest hot button topic that is changing the current game of football (at all levels) is the concussion crisis, or Chronic Traumatic Encephalopathy (CTE).

As not only the players, but all of us have become more aware and more educated of the risks associated with playing football, coaches and Universities have had to step up and create changes in order to make the game we love safer for those who play it. The topic has been of great interest to me, and a little under two years ago I came across a company (Mercaptor Discoveries) that is making ground breaking research in the treatment and prevention of CTE. I had the opportunity to speak with their CEO, Sara Isbell, in 2018 to learn little more about what they are developing. And I spoke with her again this past week. Heres a recap of my original interview with Sara, and an update on what Mercaptor is currently working on.

What is your academic/career background before joining Mercaptor Discoveries?

I have a B.S. in Neurochemistry, Biochemistry, Molecular Biology from University of Irvine, Calif. I worked at Genentech early in my career and was a Senior Researcher at Raptor Pharmaceuticals for 12 years. In 2017, I co-founded Mercaptor Discoveries.

Do you have any previous association with the game of football?

I do not have much previous association with football, aside from watching games with my dad when I was growing up. But I am so happy that the drug I am developing could potentially impact the lives of so many athletes, from kids to pro NFL players. The concussion crisis is finally being acknowledged, so I am happy that we may be able to help people avoid serious lifelong complications from doing something they love like playing football.

How did you become interested in researching CTE and football related brain injuries?

I am a neuroscientist but I was in the process of researching something else when my team and I stumbled upon this discovery. Then we realized the implications this breakthrough molecule could have for so many neurodegenerative conditions.

Can you explain the current concussion medication that your company is working on?

Our molecules, called captons, prevent trauma from spreading throughout the brain. By halting the progression of the initial damage caused by concussions, the medication would prevent long-term repercussions like ALS and other progressively degenerative diseases from developing. Captons could prevent or treat chronic traumatic encephalopathy (CTE), alcohol withdrawal, chemobrain, Alzheimers disease, Parkinsons disease, and epilepsy.

In Mercaptors most recent research, they have been applying their technology to the prevention and treatment of seizures, and they have efficacy data which proves their captons can be used to help seizure patients. Their model has been checking to see if the captons can quiet the brain after a traumatic event, such as a seizure, TBI or concussion. Once this model can be moved into clinical trials and proven, the technology can then be applied to even more traumatic brain events.

Today, the treatment for seizure patients involves the patient taking a drug or drugs which quiet the brain from firing. These drugs cannot be targeted to a specific part of the brain, but are absorbed by the entire brain; to the healthy and not healthy parts of the brain. These medications make the patient drowsy, and being that they have to take the medications every day, this oftentimes mean they cannot work or drive as a result of these side effects.

When these drugs are captonized, using a chemical trick to turn them into a Capton, they become inactive versions of themselves. (Many drugs have the right chemical properties to be captonized.) As a Capton, the drug also gains higher brain penetration. The drug will remain inactive, evenly distributed throughout the brain, until a traumatic brain event occurs, such as a seizure or concussion. When the traumatic brain event occurs, the drug is then activated in the exact place where it is needed, and not everywhere in the brain. This would allow people to take anti-seizure medication and not be drowsy, and the medication would only kick in when a seizure started.

Their research is also showing that this technology could be slightly modified and then applied to strokes, alcohol withdrawal, Alzheimers ... the applications are endless. Never before in history have we been able to use a molecule to administer medication quietly, and only work when needed. The scientists at Mercaptor are confident that once they can prove the success of this technology with seizure patients, that they will be able to apply this technology to more than just traumatic brain events, but to conditions they havent even thought of yet.

How did former NFL player Jim Kovach become a part of Mercaptor Discoveries and what is his involvement?

Jim joined our Board of Directors after looking at our science. As a medical doctor and former football player, he is in a unique position to work toward finding solutions to the concussion crisis that is plaguing the NFL.

In a quote from Jim Kovach, Jim explains the grave reality that it is practically impossible to make the game of football truly safe for its players. This is why the research being done by Mercaptor is so important in saving the game of football. With just the amount of physics that I learned to get into medical school and the knowledge of the forces within the brain, says Jim Kovach, a medical doctor, lawyer, entrepreneur, and former player, my personal opinion is that it would be impossible to truly mitigate the coup-contrecoupthe shaking of the brain, the physical contusion of the brain and the cerebrospinal fluid that is caused by head impacts.

Where do you hope this research/medication will be in 10 years? 20 years? And could this save the game of football?

We believe this medication will be used widely to prevent brain injury in contact sports. Yes, captons could save the game of football! Athletes could play football without the fear of long-term repercussions this would literally be a game-changer for football and so many other sports.

This discovery is not far from being in humans. If we can get the funding, we can be in the clinic in two years and to the market in an additional three years. Our approach works on the biochemical level, which is translatable between animals and humans. Unlike other drugs that have been developed and have fallen short after animal studies, our medication being in pre-clinical phase for the next three years will guarantee success in humans.

Since this is an entirely new approach to fighting brain injury and disease, attracting funding is a challenge. It takes a special kind of investor who is willing to take a big leap. We are hoping that our work will attract funding from people who are passionate about changing the world for the better. To learn all about Mercaptors vision, visit http://www.mercaptordiscoveries.com

Read the original here:
Ground Breaking CTE Research May Save the Future Game of Football - One Foot Down

Could invisible aliens really exist among us? An astrobiologist explains – The Conversation UK

Life is pretty easy to recognise. It moves, it grows, it eats, it excretes, it reproduces. Simple. In biology, researchers often use the acronym MRSGREN to describe it. It stands for movement, respiration, sensitivity, growth, reproduction, excretion and nutrition.

But Helen Sharman, Britains first astronaut and a chemist at Imperial College London, recently said that alien lifeforms that are impossible to spot may be living among us. How could that be possible?

While life may be easy to recognise, its actually notoriously difficult to define and has had scientists and philosophers in debate for centuries if not millennia. For example, a 3D printer can reproduce itself, but we wouldnt call it alive. On the other hand, a mule is famously sterile, but we would never say it doesnt live.

As nobody can agree, there are more than 100 definitions of what life is. An alternative (but imperfect) approach is describing life as a self-sustaining chemical system capable of Darwinian evolution, which works for many cases we want to describe.

The lack of definition is a huge problem when it comes to searching for life in space. Not being able to define life other than well know it when we see it means we are truly limiting ourselves to geocentric, possibly even anthropocentric, ideas of what life looks like. When we think about aliens, we often picture a humanoid creature. But the intelligent life we are searching for doesnt have to be humanoid.

Sharman says she believes aliens exist and theres no two ways about it. Furthermore, she wonders: Will they be like you and me, made up of carbon and nitrogen? Maybe not. Its possible theyre here right now and we simply cant see them.

Such life would exist in a shadow biosphere. By that, I dont mean a ghost realm, but undiscovered creatures probably with a different biochemistry. This means we cant study or even notice them because they are outside of our comprehension. Assuming it exists, such a shadow biosphere would probably be microscopic.

So why havent we found it? We have limited ways of studying the microscopic world as only a small percentage of microbes can be cultured in a lab. This may mean that there could indeed be many lifeforms we havent yet spotted. We do now have the ability to sequence the DNA of unculturable strains of microbes, but this can only detect life as we know it that contain DNA.

If we find such a biosphere, however, it is unclear whether we should call it alien. That depends on whether we mean of extraterrestrial origin or simply unfamiliar.

A popular suggestion for an alternative biochemistry is one based on silicon rather than carbon. It makes sense, even from a geocentric point of view. Around 90% of the Earth is made up of silicon, iron, magnesium and oxygen, which means theres lots to go around for building potential life.

Silicon is similar to carbon, it has four electrons available for creating bonds with other atoms. But silicon is heavier, with 14 protons (protons make up the atomic nucleus with neutrons) compared to the six in the carbon nucleus. While carbon can create strong double and triple bonds to form long chains useful for many functions, such as building cell walls, it is much harder for silicon. It struggles to create strong bonds, so long-chain molecules are much less stable.

Whats more, common silicon compounds, such as silicon dioxide (or silica), are generally solid at terrestrial temperatures and insoluble in water. Compare this to highly soluble carbon dioxide, for example, and we see that carbon is more flexible and provides many more molecular possibilities.

Life on Earth is fundamentally different from the bulk composition of the Earth. Another argument against a silicon-based shadow biosphere is that too much silicon is locked up in rocks. In fact, the chemical composition of life on Earth has an approximate correlation with the chemical composition of the sun, with 98% of atoms in biology consisting of hydrogen, oxygen and carbon. So if there were viable silicon lifeforms here, they may have evolved elsewhere.

That said, there are arguments in favour of silicon-based life on Earth. Nature is adaptable. A few years ago, scientists at Caltech managed to breed a bacterial protein that created bonds with silicon essentially bringing silicon to life. So even though silicon is inflexible compared with carbon, it could perhaps find ways to assemble into living organisms, potentially including carbon.

And when it comes to other places in space, such as Saturns moon Titan or planets orbiting other stars, we certainly cant rule out the possibility of silicon-based life.

To find it, we have to somehow think outside of the terrestrial biology box and figure out ways of recognising lifeforms that are fundamentally different from the carbon-based form. There are plenty of experiments testing out these alternative biochemistries, such as the one from Caltech.

Regardless of the belief held by many that life exists elsewhere in the universe, we have no evidence for that. So it is important to consider all life as precious, no matter its size, quantity or location. The Earth supports the only known life in the universe. So no matter what form life elsewhere in the solar system or universe may take, we have to make sure we protect it from harmful contamination whether it is terrestrial life or alien lifeforms.

Read more: Elon Musks Starship may be more moral catastrophe than bold step in space exploration

So could aliens be among us? I dont believe that we have been visited by a life form with the technology to travel across the vast distances of space. But we do have evidence for life-forming, carbon-based molecules having arrived on Earth on meteorites, so the evidence certainly doesnt rule out the same possibility for more unfamiliar life forms.

View original post here:
Could invisible aliens really exist among us? An astrobiologist explains - The Conversation UK

Food security, international students: What the new GPSC president has been focused on – Duke Chronicle

Every vice president knows they may have to take over for the president, but rarely does that situation come to fruition.

The sitting president of the Graduate and Professional Student Council, Anthony Monroe, stepped down from the position in October, leaving vice president Alyssa Florwick to fill his shoes. As GPSC President, Florwick, a Ph.D. student in biochemistry, aims to carry forward the visions of the GPSC throughout the year by continuing efforts with the Community Pantry, centralizing resources and supporting international students.

Wed already laid a lot of foundational work, she explained. I talked to Anthony earlier in the year about some of the goals he wanted to carry forward. Highlighting the Community Pantry is a continued mission of ours, and I think were really broadcasting that a lot.

From its founding in 2017, the Community Pantry has provided resources like food, professional clothing and childcare items to graduate students. GPSC will host a campus food insecurity symposium Feb. 14 based on a collaboration between Duke, the University of North Carolina Chapel Hill and Durham Technical Community College, Florwick said.

Its highlighting essentially the issues, the stigma around food insecurity and the ways of moving forward about how campuses can support students, she said.

Florwick wants GPSC to continue to centralize and highlight various campus resources for students through projects such as the existing Resource Directory Task Force. She emphasized that though there is a bounty of resources available to help Duke students, theyre just really not centralized and broadcasted in a way that students are aware of.

She is currently working on a resource directory page on the GPSC website that is expected to be published by April.

Florwick also expressed an interest in working toward expanding resources available for international students at Duke. She hopes to help international students receive internships to enhance their graduate careers.

The general sentiment is that, especially students who come internationally and come with families and their spouses, may not be able to get a visa to work and dont oftensome indication that theres a financial need there, Florwick said.

She explained that schools like the Sanford School of Public Policy have a lot of professional degrees where internship experience is really integral for their success. However, there is a little bit of a disconnect between how students know they can get those internships, if they knew beforehand that they could get those, she added.

Under Florwicks leadership, GPSC created the Task Force on International Student Affairs. The representatives are now discussing the creation of an international student internal committee within GPSC that could collect more data on international students to understand what resources the council could potentially offer.

We want to know more about students who identify in that population without making them feel like were trying to target or identify them out, she said.

Signup for our editorially curated, weekly newsletter. Cancel at any time.

The task force for international students is just one of four select task forces that the executive committee approved during their current term, along with parking and transportation, sustainability and resource directory.

She also hopes to bring students from various schools together to build collaboration efforts, such as the collaboration of the Graduate School with all other nine schools at Duke for a graduate and professional student appreciation week.

The Graduate School has done a graduate appreciation week in the past and were working with them to broaden that and in that are trying to create opportunities to have students and student leaders from the other schools provide input, she said.

Florwick wishes to strengthen the relationship between GPSC and Duke Student Government as well.

I actually met with [DSG President Liv McKinney] this semester to talk about whats going on with DSG and what theyre doing because I feel like we can learn a lot from each other, she said.

She emphasized that some of the issues being tackled by GPSC task forces, such as the Task Force on Parking and Transportation, are issues for all members of the Duke community, not just graduate and professional students.

In addition to working more with the undergraduate population, Florwick is determined to understand her own population more deeply.

One thing that Im really focusing on this year is trying to understand the heterogeneity of graduate and professional students because I think thats something we struggle with as well, she said. Were the advocates and the voices for our students and we want to be seen and know that students can reach out to us while also having the right things to advocate about.

Read more:
Food security, international students: What the new GPSC president has been focused on - Duke Chronicle

Why people usually have an A-ha moment before they lose weight – KSTU FOX 13 Salt Lake City

Dr. Kristen Kells, a Chiropractic Physician, is an authority when it comes to weight loss. She's not only studied it in-depth, but she's been there, done that! Dr. Kells lost over 80 pounds personally and has kept it off for the last 15 years.

Dr. Kells says usually there is an "A-ha" moment when people realize they've got to lose weight. For her, it was after her son was born when she was at her highest weight. Dr. Kells say she was depressed, hopeless and felt like she'd tried everything! For her, she had to address her weight loss resistance, something she now does in her offices. Dr. Kells says when you address the underlying biochemistry (hormones, body PH, toxicity) it will help you fix your broken metabolism and correct weight loss resistance.

So how do you know if you have weight loss resistance? Dr. Kells says if you've tried everything and still can't lose the weight, and if you have some of these typical symptoms: brain fog, wired and tired, no energy, low libido, digestive issues, cravings or if you felt like she did - hopeless and discouraged, you may have it.

But it doesn't have to be that way. Stephanie Bezyack, a client of Dr. Kells, joined us to talk about the great results she's had. She lost 28 pounds in 14 weeks and has kept it off for four months. Stephanie says she has more energy and is feeling better about herself as a whole.

If you'd like to check out Dr. Kells Weight Loss Program, call (385) 217-3834 to schedule a free, no-obligation consultation. Dr. Kells' team is standing by to take your call. They have spots reserved for the first 15 Fox 13 callers - so call now!

For more information please visit: drkellsweightloss.com.

Excerpt from:
Why people usually have an A-ha moment before they lose weight - KSTU FOX 13 Salt Lake City

Has the chemistry Nobel prize really become the biology prize? – Chemistry World

Not another chemistry Nobel going to biologists! How many times have you heard that complaint? But is there really anything in it?

Its sometimes said that the number of chemistry prizes awarded to work rooted in the life sciences at least nine of the prizes since 2000 simply shows how broad chemistry is: at the molecular scale, biology is chemistry. But does that argument stack up? A historian of chemistry and a mathematical chemist argue in a new paper that, not only have the chemistry Nobels indeed become more biological in recent decades, but also the prizes of that nature tend to reward work outside of the chemical mainstream, being much more closely tied to research in the life sciences itself. In effect, they say, the chemistry Nobels are being shared out between genuinely different disciplines.

The two researchers, Jeffrey Seeman of the University of Richmond in the US and Guillermo Restrepo of the Max Planck Institute for Mathematics in the Sciences in Leipzig, Germany, say that the chemistry Nobel has now mutated into what is effectively the Nobel prize in chemistry or life sciences. They call for this to be openly acknowledged, rather than disguised with a pretense that its all chemistry. Whats at stake here is not just a matter of justice about who gets the most prestigious of all scientific awards, but the de facto boundaries of chemistry as a discipline.

Seeman and Restrepo show that the proportion of chemistry Nobels awarded for achievements in the life sciences has grown fairly steadily from around one per decade in the early 20th century to four to five per decade since the 1980s.1 They quote geneticist Jan Lindsten and cell biologist Nils Ringertz, both of whom served on the the Nobel Committee for Physiology or Medicine in the 1980s, who wrote that many chemistry laureates have made contributions which might equally well have been awarded a prize in physiology or medicine.

Chemistry Nobel laureate Roald Hoffmann of Cornell University in the US, has previously viewed this trend as a call to our profession to embrace the far and influential reach of chemistry. But does it really reflect what chemistry is up to today?

No one can doubt that biochemistry has been a part of chemistry since its earliest days: Antoine Lavoisier studied respiration and fermentation, Justus von Liebig studied metabolism, and fermentation was central to the chemical understanding of enzyme catalysis. But might the disciplines have now gone their separate ways, with distinct communities, journals and spheres of influence? To answer that question, Seeman and Restrepo analysed the papers in two journals throughout 2007, chosen to be representative of mainstream chemistry and biochemistry: Angewandte Chemie International Edition and the American Chemical Societys Biochemistry. They looked at the citations made in papers in the two journals to those in other journals, and vice versa, to get a picture of the web of intellectual relationships.

We found that the chemistry journal has a flow of knowledge mainly with other chemistry journals and very little with life sciences journals, says Restrepo. The same for the biochemistry journal: it was by far more related to life science journals than to chemistry ones.

In other words, says Restrepo, there is a core community of chemistry, that we detected using bibliometric methods, which is not that related to its sibling biochemistry. The kinds of biologically oriented papers that garner chemistry Nobels arent really a part of the chemistry literature at all, he says the two fields belong to intellectual territories that are quite distant from each other. This, he and Seeman say, is the organic result of how scientific communities form and maintain themselves and presumably reflects an unspoken perception that the questions and goals of the communities are different.

The researchers used similar bibliometric analysis to look at the influence of chemistry Nobel laureates, and found that most awards are quite polarised, either being cited almost exclusively in the physical (typically chemical) or the life sciences.

Disciplinary divisions are built into the way the Nobel awards operate. They are awarded by the Nobel Foundation under the auspices of the Royal Swedish Academy of Sciences. The Academy elects members each year who are assigned to one of 10 categories, such as physics, chemistry and the biosciences, and selects the Nobel committees from these members. It stands to reason, then, Restrepo says, that if the Academy elects more life scientists than chemists, and if the Nobel Committee for Chemistry becomes weighted more heavily in life scientists, then it is likely that more of the Nobel prizes in chemistry will be in the life sciences.

Seeman and Restrepo studied the disciplinary composition of the chemistry Nobel committees, and found a clear linear correlation between the proportion of awards in the life sciences per decade and the proportion of committee members from those backgrounds: both figures have increased steadily since the prizes began. In the last 70 years, the proportion of chemistry committee members from the life and biochemical sciences has been 4060%.

So what, if anything, is to be done? We are not suggesting that chemists should fight their own corner, but that they, and awarding institutions, should be aware of the territory of chemistry, its shape and reaches, says Restrepo.

Is the current structure of the Nobel prizes optimal for the future? the pair asks. The evidence is: certainly not. In a way, the Nobel Foundation and the Nobels prize-awarding bodies have produced a patchwork of change over the past several decades, a force-fit into the schema of Alfred Nobel. That strategy will not suffice forever.

With this in mind, they suggest several possible changes to the ways the Nobel awards operate. For example, it could include leading international representatives of the most active and most influential fields of chemistry in the Nobel Committee for Chemistry. The limit of three recipients each year could be relaxed to broaden the pool of laureates and the Foundation could publicly document the criteria and disciplinary boundaries for each of its prizes and for membership on the Nobel Committees.

Perhaps one of the suggestions they could easily implement is the use of bibliometric tools to keep track of the evolution of the disciplines and also as a tool to assist the selection of members of the committee, says Restrepo.

Robert Lefkowitz of Duke University in Durham, North Carolina, who won the 2012 chemistry Nobel with Brian Kobilka for work on G-protein coupled receptors, doesnt buy it. I think it is a silly argument based on definitions, he says.

He points out that most standard definitions of chemistry include biochemistry as a branch. Is there anything in Alfred Nobels will that says the different branches need to be equally rewarded? he asks. It simply says instead that the prize should go to those whose discoveries have conferred the greatest benefit to humankind. If the Nobel committee decides that the greatest benefit has come disproportionately from biochemistry, and Lefkowtiz agrees that this has been so in recent years, then so be it. But I understand that these other chemists feel disenfranchised, he says. I would too.

In any event, he says, the choice is up to the Swedes, whereas Seeman and Restrepo seem to be saying that the prize is owned by all of us.

And while a common complaint is that the life sciences already have their own prize, Lefkowitz points out that it is actually a prize for physiology and medicine but when was the last time a physiologist or physician actually won it for work in those fields? Almost never, Lefkowitz says. It more often goes to biochemists than does the chemistry prize. Similar arguments rage in other disciplines too: some say particle physics is inordinately represented in the physics prize, for instance, while in the early 20th century the turf wars were more between physics and chemistry as awards went to discoveries in radioactivity and atomic physics.

Seeman and Restrepo interacted extensively with members of the Nobel committee as they prepared their paper, in particular to clarify the procedures of the Nobel Foundation. They stress that the committee members were extremely responsive, cooperative and helpful. Protein chemist Gunnar von Heijne of Stockholm University, Sweden, current secretary of the chemistry Nobel committee, finds food for thought in the paper but doesnt think that the findings demand any more changes or soul-searching than are already happening.

It is certainly not true that the Nobel prize in chemistry has developed into a Nobel prize in life sciences, he says, speaking in a personal capacity. He thinks that the alleged intellectual separation of chemistry and biochemistry rests on circular reasoning: that biochemists tend to publish in pure biochemistry journals seems unsurprising, but doesnt in itself make biochemistry distinct from the rest of chemistry.

Von Heijne says that it is hard to implement changes to the Nobel Foundations procedures anyway. It is the statutes of the Nobel Foundation and, ultimately, the will of Alfred Nobel, that provide the basic framework for the Nobel prizes, [including] the prize areas. This basic framework cannot and probably should not be easily changed. He adds that the Nobel prizes rest on a finely tuned and slowly evolving system of rules and procedures, and major changes can easily create more problems than they solve.

On the suggestion that the Nobel committee should include the most active and influential scientists in each field, for example, he says that over the years that Ive served on the Nobel Committee, Ive become convinced that it is much easier for a rather close-knit group of scientists living in a far-off country to take the necessary detached view of the world of science that the responsibility of proposing Nobel prizes carries with it and to put in the months of work required every year than it would be for a committee of busy international high-flyers.

And increasing the number of laureates for a given prize would simply widen the arguments about where the cutoff lies, he says. In my own experience, the number of deserving individuals grows rapidly with the number of laureates included in a prize. There would be many more candidates of more or less equal merit to consider for a fourth slot than for the first, second or third slot.

While Restrepo says that one of the aims of the paper is to bring into the open some of the opacity of the Nobel prize process, von Heijne feels that too explicit and formulaic a selection process could create a straitjacket. If, for example, some formal and publicly stated definition of what counts as chemistry were to be drawn up, it would need to be constantly revised with every passing year indeed, it would be outdated even before it is decided. Von Heijne says that his own preference is to be inclusive and recognise the broad reach of chemistry in contemporary science and technology. Lefkowitz thinks that the chemistry Nobel actually has had some of the most creative and original committees in recent decades, for example making awards for work in microscopy or materials science. They surprise people year after year, he says.

So perhaps some fuzziness and secrecy is best after all. If the Nobel prizes were selected by algorithm, what would we have to argue about every October?

See the article here:
Has the chemistry Nobel prize really become the biology prize? - Chemistry World

Protein Structure Associated with Inherited Retinal Diseases is Solved – Technology Networks

Researchers at the University of New Hampshire have reported the first structural model for a key enzyme, and its activating protein, that can play a role in some genetically inherited eye diseases like retinitis pigmentosa and night blindness.

There has been substantial research on the biochemical pathway involving this enzyme, known as PDE6, but defining atomic-level models is important for locating PDE6 mutations in order to understand why they cause disease and how we can develop new therapeutic interventions to manage retinal diseases, said Rick Cote, director of Center of Integrated Biomedical and Bioengineering Research and principal investigator on the study.

Vision starts in the photoreceptor cells of the retina which contains rods, responsible for low light vision, and cones, which are active in brighter light and capable of color vision. When light is absorbed by the rods and cones, it triggers a pathway which activates the enzyme phosphodiesterase 6, or PDE6. This generates a nerve impulse to the brain that ultimately results in visual perception. Some genetically inherited eye diseases are caused by mutations to PDE6, or its activating protein, transducin, that can lead to disruptions of normal vision or even total blindness.

In the study, researchers reported how they were able to use chemical cross-linking combined with mass spectrometric analysis to resolve the structure of PDE6 in its nonactivated and transducin-activated states. This approach permitted visualization of flexible regions of individual PDE6 catalytic and inhibitory subunits that were poorly resolved in previous work as well as the overall molecular architecture of the activated protein complex.

Determining the structure of these visual signaling proteins has always been a challenge because of their complexity, said Michael Irwin, doctoral student in biochemistry and lead author. Having detailed structural information about how PDE6 is activated by transducin will help us understand the molecular causes of visual disorders and blinding diseases resulting from mutations in these proteins.

Current medical treatment for such genetically inherited retinal diseases may include gene therapy or drugs meant to inhibit the disease process. However, they are not always successful in restoring the balance of PDE6 and preventing blindness. Scientists believe that knowing the molecular structures of these visual signaling proteins and how they interact with each other can offer clues for the development of new drugs to both restore vision and prevent blindness.

Reference

Irwin et al. (2019) The molecular architecture of photoreceptor phosphodiesterase 6 (PDE6) with activated G protein elucidates the mechanism of visual excitation. Journal of Biological Chemistry. DOI: https://doi.org/10.1074/jbc.RA119.011002

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

See the original post here:
Protein Structure Associated with Inherited Retinal Diseases is Solved - Technology Networks

Interview: Dr Andrew Morgan on the microbiome – fundamental to both health and disease – All about feed

Some 30 years ago Dr Andrew Morgan got involved in studying the microbiome and he has played an important role in the development of DuPonts microbiome platform. Even as a schoolboy he was inspired by the emerging field of modern biology when he read the book What is life? by Erwin Schrdinger.

When I first became involved in working with enzymes for animal nutrition back in the late 1980s, there was hardly any understanding of the interaction between nutrition, the microbiome, and the gut and immune function of neither animals nor humans. In fact, the term 'microbiome' wasnt used at the time. The discipline of nutribiosis, as we call it now, was still in its infancy. Since then, we have come a long way and we have been amazed by the interactions between the microbes that live in the gut and the host physiology that maintains a healthy or homeostatic state, says Dr Andrew Morgan.

Dr Andrew Morgan is a DuPont Fellow at DuPont Nutrition & Biosciences and was Chief Scientist for the DuPont Nutrition & Health and legacy Danisco businesses for over a decade. He is involved in both the human and animal nutrition sides of the business. Dr Morgan has an impressive career, starting at BP Research, BP Nutrition (= Nutreco today), Finnfeeds and then moving on to Danisco and now DuPont. Dr Morgan has a First Class Honours Degree in Biochemistry and is a Doctor of Philosophy in Microbial Biochemistry & Genetics (University of Sussex).

He gave a presentation during the recent first conference of World Rising Nutritionists 2019 in Lisbon, providing deep knowledge into the science around the 3 pillars of nutribiosis, namely:

The gut is the main reservoir of microbes in the body, with about 30% of metabolites in the bloodstream originating from the gut microbes and so it should not be too surprising that gut microbes have a strong relationship with health. Dr Morgan continues: Microbes make us what we are: ultimately all living organisms evolved from microbes and have learned to co-exist with them. In humans tens of trillions of microbes populate our bodies, both inside and out. The composition and behaviour of bacteria in the gut is critically important for human and animal health.

At the start of my involvement in the then nascent field of the way enzymes affect animal nutrition in 1989, I started by reading the scientific literature available to get a better understanding of animal nutrition and the potential role that enzymes could play in animal nutrition and health. At the time, there were 3 theories of how enzymes might affect animal nutrition. One was based on a correlation between viscosity in the gut and performance; another suggested that enzymes degrade the cell walls of feed materials and release additional nutrients and the third my own theory was that enzymes had an influence on the composition of the gut microflora. Thats when we started to work on testing these hypotheses and today we know that they were all correct.

Dr Andrew Morgan, a DuPont Fellow at DuPont Nutrition & Biosciences. Some 30 years ago he got involved in studying the microbiome and he has played an important role in the development of DuPonts microbiome platform. Photo: Dupont

From that time onwards knowledge and developments really shifted into top gear. In the early 1990s we focused on enzymes that degrade NSP for animal nutrition and over time we built the tools needed to study the different mechanisms of action including DNA-based methods for monitoring shifts in the gut microflora (microbiota) composition. By the mid-1990s we were able to clearly demonstrate that NSP-hydrolysing enzymes depolymerise high molecular weight arabinoxylan and betaglucan substrates, thus generating small polymers and oligosaccharides; the result was a favourable shift in the microflora/microbiota composition. By the early 2000s we had built a health and nutrition toolbox (Enteromix), including GI tract simulation and cell line models that supported our research and development for both human and animal applications. We have added substantially to these in recent years, including models from metagenomics, metabolomics and bioinformatics. That knowledge platform really showed its value when we started to work on probiotics in the mid 2000s. With our health & nutrition platform, as well as leading manufacturing and formulation capabilities, we were able to develop state-of-the-art probiotic science and technology which supports the development of a substantial portfolio of products and that is what brought us to where we are today. DuPont has a very strong position in enzymes, fibres, prebiotics and probiotics.

Giving good bacteria the upper hand over the bad is the reason why we launched our microbiome venture in 2017." - Dr Morgan.

Dr Morgan continues: And were not done; were focusing on the future. Our platform is now designed to produce next-generation probiotics and other kinds of microbiome modulator. We have established a Microbiome Venture to develop new human microbiome solutions, but that knowledge is also readily transferable to the animal side of the business. A lot of research is being done on next-generation probiotics and on molecules that modulate the microbiome. We are especially building on our strengths in Lactobacillus and Bifidobacterium probiotics, where today we have an industry leading portfolio of scientifically documented strains. In humans, we are tailoring solutions to certain health conditions and age criteria, including solutions for early life when the microbiome is just getting established in the infant. In fact, we already have probiotic offerings for early life that build on over a decade of research and recently we launched a human milk oligosaccharide (HMO) product; HMOs present in breast milk play an important role in shaping the infant microbiome.

Giving good bacteria the upper hand over the bad is the reason why we launched our microbiome venture in 2017 to shape a whole new range of solutions. We know that the diet we eat and our lifestyle is essential to health, but when things go wrong with the microbiome so-called dysbiosis we want to find solutions that help shift the balance back towards homeostasis. This is a long-term endeavour, but we are one of a very few companies with the full range of capabilities needed to succeed. The expectation that we will be able to prevent disease and support health in both humans and animals by influencing the microbiome in a far more targeted way is both promising and exciting.

As a bonus, it will help to solve the rise of antimicrobial resistance as well, because, with greater understanding of the microbiome, alternative more targeted solutions will emerge and the need to use antibiotics will decline. If one looks at it in a holistic way, one can conclude that microbiome science holds the promise of fundamentally new solutions designed to support health and prevent disease that will beneficially impact both animal and human health and nutrition for years to come.

See the original post:
Interview: Dr Andrew Morgan on the microbiome - fundamental to both health and disease - All about feed

Impeachment: What you need to know, students react – The State News

On Dec. 18, 2019, the House of Representatives voted to approve articles of impeachment against President Donald Trump.

Trump was impeached on the grounds of abuse of power and obstruction of Congress.

The abuse of power article stems from a whistleblower complaint that accused Trump of asking Ukrainian President Volodymyr Zelensky to investigate 2020 Democratic presidential candidate Joe Bidens son in exchange for previously authorized military aid Trump had cut. The whistleblowers memo and a summarized transcript of the phone call between Trump and Zelensky have since been released.

The obstruction of Congress article was brought due to Trumps refusal to comply with congressional subpoenas, according to NBC.

Trump is the third president in U.S. history to be impeached, joining Andrew Johnson and Bill Clinton.

Impeachment was a controversial decision, with the vote decided almost entirely along party lines, with just two Democrats, Collin Peterson and Jeff Van Drew, voting against both articles of impeachment and another, Jared Golden, voting against obstruction of Congress, according to The New York Times. No Republicans voted in favor of impeachment.

Up next is a vote in the Senate to decide whether or not to remove Trump from office. Senate majority leader Mitch McConnell has said there will be a trial before the vote.

Speaker of the House Nancy Pelosi is withholding the articles until Democrats can reach an agreement with McConnell on how a Senate trial should proceed. Democrats want four Trump officials to testify, while McConnell has said hell only allow the evidence from the House trial to be used, according to CNN.

The Senate will vote on trial parameters. If the Democrat and Independent vote is united, theyll need four Republicans to join them, according to the Senates website.

For Trump to be removed, two-thirds of the senate will have to vote in favor of removal. The Senate has a Republican majority. Given the close party lines the House vote followed, removal is unlikely unless new evidence comes out.

Ahead of the Senate vote, The State News gathered student opinions on Trumps impeachment.

Psychology and neuroscience sophomore Kate Frieden said she believes Trumps impeachment is a defining moment in his presidency.

Its such a monumental moment in history, Frieden said. When Im an adult and I have my own kids, my kids are going to be like, What was it like living in Trumps America? ... I have very, very little hope that anything will be done, but I hope that a fair trial is given.

Pre-veterinary sophomore Jacobo Bacariza said Trumps willingness to exercise his power as president is something Congress isnt used to.

Hes definitely using it unlike our previous presidents, Bacariza said. America spoke a few years back, and we wanted Trump as our president. ... (Trumps) someone that you cant really beat right now, and you just have to wait until he serves his two terms.

Bacariza said Democrats impeached Trump because they cant win in the 2020 election.

Lindsay Guare, a junior triple majoring in computer science, biochemistry and genetics, said shes glad hes being held accountable.

(Impeachment is necessary) in order to show that we uphold people to a certain standard. Guare said.

Here is the original post:
Impeachment: What you need to know, students react - The State News